Developer docs
API playgroundTry for free, no card

Search company profiles

Vesey Street Capital Partners

Full company profile

uuid0000gyp

Namestring
Vesey Street Capital Partners
Legal namestring
Vesey Street Capital Partners, L.L.C.
Websiteurl
vscpllc.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Vesey Street Capital Partners (VSCP) is a New York-based private equity firm founded in 2014 that specializes in control buyouts of lower middle-market healthcare services companies in the United States. The firm targets businesses with $10M–$20M in EBITDA and deploys $75M–$120M equity checks, pursuing target returns of 3x MOIC and 25% IRR through a combination of organic growth and M&A tuck-ins using conservative leverage. Since inception VSCP has deployed more than $1 billion in equity capital across 47 transactions and 13 platform companies spanning physician services, life sciences services, hospital services, payor services, consumer-oriented healthcare, and healthcare education.

VSCP has no proprietary technology platform; its value proposition rests on the senior team's 30-year working relationships and 100+ combined years of healthcare services expertise spanning Wall Street and operating executive roles. The firm differentiates itself through proprietary deal sourcing via what it describes as an "unprecedented network" in healthcare services, and through hands-on portfolio collaboration. The portfolio includes Shemmassian Academic Consulting, Orthopaedic Solutions Management, Elite Body Sculpture (AirSculpt Technologies), Safecor Health, Inceptua Group, ComplexCare Solutions, PathGroup, Exponent Health, and previously exited holdings Imedex (sold to HMP in 2017 with reportedly 10x+ return), QualityMetric (sold in 2023), and Gastro MD (sold in 2025).

Revenue is generated through traditional private equity fund management: management fees on committed capital plus carried interest on successful exits, on behalf of Limited Partners including asset management firms, family offices, pension funds, and institutional investors. Fund II was reported as targeting $200 million in 2018. The firm is led by Founder and Managing Partner Adam Feinstein and has expanded its Strategic Advisory Board in 2026 with Kurt Hilzinger (Chairman of Humana), Lance Berberian (former CIO of LabCorp), and Joe Sowell (former CDO of HCA Healthcare).

Short descriptiontext

Vesey Street Capital Partners is a New York-based private equity firm founded in 2014 that specializes in control buyouts of lower middle-market US healthcare services companies with $10M–$20M EBITDA, deploying $75M–$120M equity checks and managing capital for institutional limited partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity firm, healthcare buyouts, middle-market investing, healthcare services investment, fund management
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Portfolio Management and Investment Advice52394
SIC code2 codes
  • Investment Advice6282
  • Security Brokers, Dealers & Flotation Companies6211
Product category
Private Equity Investment Management
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Private Equity Fund Management
TypeManaged Services
Description

VSCP generates returns through private equity fund management, deploying capital in lower middle-market healthcare services buyouts. Revenue is derived from management fees on committed capital and carried interest (performance fees) on successful exits. The firm has deployed over $1 billion in equity capital across 47 transactions.

vscpllc.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Vesey Street Capital Partners is a private equity firm that makes control buyout investments in lower middle-market healthcare services companies, targeting businesses with $10M–$20M EBITDA and deploying $75M–$120M equity checks per transaction. The firm invests capital on behalf of Limited Partners—including asset management firms, family offices, pension funds, and institutional investors—across healthcare subsectors such as physician services, life sciences services, hospital services, payor services, consumer-oriented healthcare, and healthcare education.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 47 transactions across 13 platform businesses
+2 more records
Product overview1 text field

Vesey Street Capital Partners is a private equity firm that operates as a single unified investment platform rather than a product company. The firm specializes in lower middle-market healthcare services buyouts, targeting companies with $10M-$20M EBITDA and deploying $75M-$120M equity per investment. VSCP's portfolio consists of healthcare services companies across physician services, life sciences services, hospital services, payor services, consumer-oriented healthcare, and healthcare education services. The portfolio companies include both active investments and exited holdings across various healthcare subsectors.

Product and service1 record
1Private Equity Investment Services
CategoryPrivate Equity Fund Management
Description

Control buyout private equity investment services targeting lower middle-market healthcare services companies with $10M–$20M EBITDA, deploying $75M–$120M equity checks per transaction on behalf of Limited Partners.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Chicago-based PE firm exclusively focused on healthcare services and life sciences businesses, deploying control investments in the lower middle market. Highly comparable to VSCP in sector focus, equity check size, and operating-partner-driven value creation approach.

TypeDirect peer
Description

Healthcare-specialist PE firm with 40+ year history investing across healthcare services, provider, payor, and technology-enabled services. Most established healthcare-focused lower middle-market PE platform, frequently compared to VSCP for sector exclusivity and physician/payor services focus.

TypeDirect peer
Description

Healthcare-services-heavy PE firm investing across services, payor, and pharma services sub-sectors. Comparable to VSCP in targeting healthcare services consolidation through platform-plus-tuck-in strategies, though at a meaningfully larger AUM scale.

TypeDirect peer
Description

Healthcare-focused middle-market PE firm with deep physician services and specialty pharma services portfolio. Directly comparable to VSCP in vertical focus, equity check size, and carve-out expertise.

TypeDirect peer
Description

Middle-market PE firm with a meaningful healthcare services vertical alongside consumer and industrial investments. Comparable to VSCP in middle-market equity check range and platform-building approach.

TypeDirect peer
Description

Healthcare-only PE firm investing in growth and lower middle-market healthcare services companies, often partnering with provider and payor strategic LPs. Closely comparable niche focus to VSCP with similar equity check profile.

TypeDirect peer
Description

Healthcare-dedicated middle-market PE firm focused on provider, services, and consumer health businesses. Comparable to VSCP in target EBITDA range, healthcare services specialization, and founder-friendly positioning.

TypeDirect peer
Description

Denver-based middle-market PE firm with explicit healthcare services vertical among its core sectors. Comparable to VSCP in lower middle-market equity check range and partnership-style approach with management teams.

TypeBroad incumbent
Description

Mega-cap PE platform with a dedicated healthcare services strategy that increasingly underwrites middle-market provider and physician services companies. Represents the larger-scale incumbent VSCP competes against for healthcare services deals.

TypeBroad incumbent
Description

Mega-fund healthcare growth and buyout strategy with broad provider, services, and life sciences coverage. Comparable as a larger-scale incumbent pursuing overlapping healthcare services targets and competing for the same founder-led businesses.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles18 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment8 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vesey Street Capital Partners

Private Equity Investment Managementvscpllc.com

Vesey Street Capital Partners is a New York-based private equity firm founded in 2014 that specializes in control buyouts of lower middle-market US healthcare services companies with $10M–$20M EBITDA, deploying $75M–$120M equity checks and managing capital for institutional limited partners.

What Vesey Street Capital Partners does

Vesey Street Capital Partners (VSCP) is a New York-based private equity firm founded in 2014 that specializes in control buyouts of lower middle-market healthcare services companies in the United States. The firm targets businesses with $10M–$20M in EBITDA and deploys $75M–$120M equity checks, pursuing target returns of 3x MOIC and 25% IRR through a combination of organic growth and M&A tuck-ins using conservative leverage. Since inception VSCP has deployed more than $1 billion in equity capital across 47 transactions and 13 platform companies spanning physician services, life sciences services, hospital services, payor services, consumer-oriented healthcare, and healthcare education.

VSCP has no proprietary technology platform; its value proposition rests on the senior team's 30-year working relationships and 100+ combined years of healthcare services expertise spanning Wall Street and operating executive roles. The firm differentiates itself through proprietary deal sourcing via what it describes as an "unprecedented network" in healthcare services, and through hands-on portfolio collaboration. The portfolio includes Shemmassian Academic Consulting, Orthopaedic Solutions Management, Elite Body Sculpture (AirSculpt Technologies), Safecor Health, Inceptua Group, ComplexCare Solutions, PathGroup, Exponent Health, and previously exited holdings Imedex (sold to HMP in 2017 with reportedly 10x+ return), QualityMetric (sold in 2023), and Gastro MD (sold in 2025).

Revenue is generated through traditional private equity fund management: management fees on committed capital plus carried interest on successful exits, on behalf of Limited Partners including asset management firms, family offices, pension funds, and institutional investors. Fund II was reported as targeting $200 million in 2018. The firm is led by Founder and Managing Partner Adam Feinstein and has expanded its Strategic Advisory Board in 2026 with Kurt Hilzinger (Chairman of Humana), Lance Berberian (former CIO of LabCorp), and Joe Sowell (former CDO of HCA Healthcare).

Vesey Street Capital Partners firmographics

Firmographics
Name
Vesey Street Capital Partners
Legal name
Vesey Street Capital Partners, L.L.C.
Website
https://vscpllc.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Vesey Street Capital Partners is a New York-based private equity firm founded in 2014 that specializes in control buyouts of lower middle-market US healthcare services companies with $10M–$20M EBITDA, deploying $75M–$120M equity checks and managing capital for institutional limited partners.
Ownership category
akta.pro rank

Where Vesey Street Capital Partners is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Vesey Street Capital Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Private Equity Fund Management: VSCP generates returns through private equity fund management, deploying capital in lower middle-market healthcare services buyouts. Revenue is derived from management fees on committed capital and carried interest (performance fees) on successful exits. The firm has deployed over $1 billion in equity capital across 47 transactions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Vesey Street Capital Partners product offering

Product offering

Core offering

Vesey Street Capital Partners is a private equity firm that makes control buyout investments in lower middle-market healthcare services companies, targeting businesses with $10M–$20M EBITDA and deploying $75M–$120M equity checks per transaction. The firm invests capital on behalf of Limited Partners—including asset management firms, family offices, pension funds, and institutional investors—across healthcare subsectors such as physician services, life sciences services, hospital services, payor services, consumer-oriented healthcare, and healthcare education.

Product overview

Vesey Street Capital Partners is a private equity firm that operates as a single unified investment platform rather than a product company. The firm specializes in lower middle-market healthcare services buyouts, targeting companies with $10M-$20M EBITDA and deploying $75M-$120M equity per investment. VSCP's portfolio consists of healthcare services companies across physician services, life sciences services, hospital services, payor services, consumer-oriented healthcare, and healthcare education services. The portfolio companies include both active investments and exited holdings across various healthcare subsectors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Private Equity Investment Services Control buyout private equity investment services targeting lower middle-market healthcare services companies with $10M–$20M EBITDA, deploying $75M–$120M equity checks per transaction on behalf of Limited Partners.

Quantifiable outcome

  • 47 transactions across 13 platform businesses
  • +2 more outcomes

Companies that use Vesey Street Capital Partners

Customer profile

Segments6 records

Ideal customer profiles2 records

Vesey Street Capital Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Vesey Street Capital Partners partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves9 records

Expansion highlights4 records

Vesey Street Capital Partners competitors and assessment

Company assessment

Direct peers

  • Linden Capital Partners: Chicago-based PE firm exclusively focused on healthcare services and life sciences businesses, deploying control investments in the lower middle market. Highly comparable to VSCP in sector focus, equity check size, and operating-partner-driven value creation approach.
  • Welsh, Carson, Anderson & Stowe: Healthcare-specialist PE firm with 40+ year history investing across healthcare services, provider, payor, and technology-enabled services. Most established healthcare-focused lower middle-market PE platform, frequently compared to VSCP for sector exclusivity and physician/payor services focus.
  • New Mountain Capital: Healthcare-services-heavy PE firm investing across services, payor, and pharma services sub-sectors. Comparable to VSCP in targeting healthcare services consolidation through platform-plus-tuck-in strategies, though at a meaningfully larger AUM scale.
  • Avista Capital Partners: Healthcare-focused middle-market PE firm with deep physician services and specialty pharma services portfolio. Directly comparable to VSCP in vertical focus, equity check size, and carve-out expertise.
  • CCMP Capital Advisors: Middle-market PE firm with a meaningful healthcare services vertical alongside consumer and industrial investments. Comparable to VSCP in middle-market equity check range and platform-building approach.
  • Health Enterprise Partners: Healthcare-only PE firm investing in growth and lower middle-market healthcare services companies, often partnering with provider and payor strategic LPs. Closely comparable niche focus to VSCP with similar equity check profile.
  • Cressey & Company: Healthcare-dedicated middle-market PE firm focused on provider, services, and consumer health businesses. Comparable to VSCP in target EBITDA range, healthcare services specialization, and founder-friendly positioning.
  • Excellere Partners: Denver-based middle-market PE firm with explicit healthcare services vertical among its core sectors. Comparable to VSCP in lower middle-market equity check range and partnership-style approach with management teams.

Broad incumbents

  • TPG Capital (Healthcare): Mega-cap PE platform with a dedicated healthcare services strategy that increasingly underwrites middle-market provider and physician services companies. Represents the larger-scale incumbent VSCP competes against for healthcare services deals.
  • KKR Health Care Strategic Growth: Mega-fund healthcare growth and buyout strategy with broad provider, services, and life sciences coverage. Comparable as a larger-scale incumbent pursuing overlapping healthcare services targets and competing for the same founder-led businesses.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Vesey Street Capital Partners social profiles

Digital presence

Vesey Street Capital Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vesey Street Capital Partners leadership team

Management profile

Number of profiles

Profiles18 records

Vesey Street Capital Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vesey Street Capital Partners M&A and investment

M&A and investment

M&A3 records

Investments8 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vesey Street Capital Partners

What does Vesey Street Capital Partners do?

Vesey Street Capital Partners is a private equity firm that makes control buyout investments in lower middle-market healthcare services companies, targeting businesses with $10M–$20M EBITDA and deploying $75M–$120M equity checks per transaction. The firm invests capital on behalf of Limited Partners—including asset management firms, family offices, pension funds, and institutional investors—across healthcare subsectors such as physician services, life sciences services, hospital services, payor services, consumer-oriented healthcare, and healthcare education.

Is Vesey Street Capital Partners a public or private company?

Vesey Street Capital Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Vesey Street Capital Partners founded?

Vesey Street Capital Partners was founded in 2014. It employs 11 to 50 people.

Where is Vesey Street Capital Partners based?

Vesey Street Capital Partners is headquartered in New York, United States, in the North America region.

How does Vesey Street Capital Partners make money?

One revenue line is on record: private Equity Fund Management.

Who are Vesey Street Capital Partners's main competitors?

Direct peers on record are Linden Capital Partners, Welsh, Carson, Anderson & Stowe, New Mountain Capital, Avista Capital Partners, CCMP Capital Advisors, Health Enterprise Partners, Cressey & Company and Excellere Partners. Broad incumbents are TPG Capital (Healthcare) and KKR Health Care Strategic Growth.

Does Vesey Street Capital Partners have an API?

No public API is recorded for Vesey Street Capital Partners.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireVesey Street Capital Partners Strengthens its Team by Announcing the Addition of Lance Berberian and Joe Sowell to its Strategic Advisory BoardVesey Street Capital Partners, a New York-based private equity firm focused on lower middle-market healthcare services, announced the addition of Lance Berberian and Joe Sowell to its Strategic Advisory Board. Berberian brings over 30 years of healthcare technology experience, most recently serving as EVP and CIO at LabCorp where he led IT strategy, AI, and robotics initiatives for a team of 5,000 professionals. Sowell joins following a 40-year career at HCA Healthcare, where as Chief Development Officer he executed over $16 billion in transactions including 27 hospital acquisitions.citybizVesey Street Capital Partners Adds Kurt Hilzinger as Vice Chairman of Strategic Advisory BoardVesey Street Capital Partners (VSCP), a private equity firm specializing in lower middle market healthcare services, has appointed Kurt Hilzinger as Vice Chairman of its Strategic Advisory Board, enhancing the firm's senior advisory capabilities. Hilzinger brings extensive healthcare sector experience, including current service as Chairman of Humana Inc. and prior involvement in the merger that formed AmerisourceBergen (now Cencora). The appointment supports VSCP's continued expansion of its healthcare investment platform, where the firm has completed 47 transactions across 13 platform companies and deployed over $1 billion in equity capital.PR NewswireVesey Street Capital Partners Strengthens its Team by Announcing Kurt Hilzinger as Vice Chairman of its Strategic Advisory BoardVesey Street Capital Partners, a New York-based private equity firm specializing in lower middle market healthcare services, has appointed Kurt Hilzinger as Vice Chairman of its Strategic Advisory Board. Hilzinger brings extensive healthcare industry experience, including serving as Chairman of Humana Inc. since 2014 and leading the landmark merger that formed AmerisourceBergen (now Cencora). The firm states the appointment expands its advisory board expertise in payor services and pharmaceutical supply chain across its portfolio of healthcare services businesses.PR NewswireVesey Street Capital Partners Named to Inc.'s Founder-Friendly Investors ListVesey Street Capital Partners was recognized on Inc.'s 2025 Founder-Friendly Investors list, which highlights private equity, venture capital, and lender firms that support founder-led companies. The firm focuses on lower middle-market healthcare companies and emphasizes mentorship and partnership in its investments. This recognition underscores its commitment to supporting founder-driven businesses.PR NewswireVesey Street Capital Partners Announces Sale of Gastro MDVesey Street Capital Partners completed its full exit of Gastro MD to AGA, LLC, an affiliate of United Digestive. Under VSCP's ownership, the company doubled its provider base, developed endoscopy centers, and opened new offices. The deal was negotiated directly without investment bankers.citybizVesey Street Capital Partners Announces Sale of Gastro MDVesey Street Capital Partners completed a full exit of portfolio company Gastro MD through a sale to AGA, LLC, an affiliate of United Digestive. Under VSCP's ownership since 2019, Gastro MD doubled its provider base, developed state-of-the-art endoscopy centers, and expanded to five locations serving the greater Orlando and Tampa areas. The transaction, conducted through direct negotiations without an investment banker, reflects VSCP's strategy of partnering with lower middle-market healthcare services companies.PR NewswireVesey Street Capital Partners Adds Three Seasoned Healthcare Industry Leaders to Strategic Advisory BoardVesey Street Capital Partners added Glenn Eisenberg, Todd Gustin, and Chip Kahn to its strategic advisory board. Eisenberg previously led Labcorp and Timken, Gustin heads Genoa Healthcare, and Kahn leads the Federation of American Hospitals. The firm has deployed about $1 billion across 43 transactions.PR NewswireVesey Street Capital Partners Adds Jim Forbes as Senior AdvisorVesey Street Capital Partners, a New York-based private equity firm specializing in lower middle-market healthcare services buyouts, has appointed Jim Forbes as Senior Advisor. Forbes brings extensive healthcare investment banking experience, having served as Vice Chairman of Investment Banking at Morgan Stanley, UBS, and Merrill Lynch, with over $200 billion in M&A advisory and $225 billion in financing transactions, including leading the $33 billion LBO of HCA Healthcare. The appointment strengthens VSCP's sourcing strategy and provides additional resources to its portfolio companies.YahooVesey Street Capital Partners Completes Corporate Carveout of ComplexCare SolutionsVesey Street Capital Partners has completed the acquisition of ComplexCare Solutions in a carveout transaction from Inovalon, marking VSCP's fifth carveout deal and its first platform investment from Healthcare Fund II. ComplexCare Solutions provides health assessments and member engagement services to health plans across the United States. As part of the transaction, industry veteran Benton Davis joins as Executive Chairman, with plans to enhance the company's value proposition and support future growth.Venture Capital Access OnlineVesey Street Capital Partners Announces Majority Recapitalization of Inceptua GroupVesey Street Capital Partners has completed a majority recapitalization of Inceptua Group, a provider of clinical trial supplies and related services. The transaction will see industry veteran Doug Cook join Inceptua as Executive Chairman, aiming to enhance the company's capabilities and support its growth initiatives. With over 25 years of experience, Inceptua looks to expand its services internationally through this partnership.